Abrika Pharmaceuticals Fort Lauderdale, FL - 33325

Abrika Pharmaceuticals is categorized under Drugs, Proprietaries, and Sundries in Fort Lauderdale, FL and active since 2008.

Abrika Pharmaceuticals was established in 2008, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Drugs, Proprietaries, and Sundries business, which does work in the B2C market, and is classified as a Drugs, Proprietaries, and Sundries, under code number 4461100 by the NAICS.

If you are seeking more information, feel free to contact Haiyung Cheng at the company’s single location by writing to 509 Sawgrass Corporate Parkway, Fort Lauderdale, Florida FL 33325 or by phoning (954) 332-3390. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Abrika Pharmaceuticals
Contact Person: Haiyung Cheng
Address: 509 Sawgrass Corporate Parkway, Fort Lauderdale, Florida 33325
Phone Number: (954) 332-3390
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 2008
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Drugs, Proprietaries, and Sundries
SIC Code: 5122
NAICS Code: 4461100
Share This Business:

Abrika Pharmaceuticals was started in 2008 to provide professional Drugs, Proprietaries, and Sundries under the SIC code 5122 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Haiyung Cheng for inquiries that concern Abrika Pharmaceuticals by calling the company number (954) 332-3390, as your correspondence is most welcome. Additionally, the physical location of the single location of Abrika Pharmaceuticals can be found at the coordinates 26.12741,-80.33282 as well as the street address 509 Sawgrass Corporate Parkway in Fort Lauderdale, Florida 33325.

For its online presence, you may visit Abrika Pharmaceuticals’s website at and engage with its social media outlets through on Twitter and on Facebook.